Addendum: sartan treatment during pregnancy

Birth Defects Res A Clin Mol Teratol. 2005 Nov;73(11):904-5. doi: 10.1002/bdra.20194.
No abstract available

MeSH terms

  • Abnormalities, Drug-Induced* / epidemiology
  • Angiotensin II Type 1 Receptor Blockers / administration & dosage
  • Angiotensin II Type 1 Receptor Blockers / adverse effects*
  • Female
  • Fetal Death* / chemically induced
  • Fetal Death* / epidemiology
  • Humans
  • Pregnancy
  • Teratogens / toxicity

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Teratogens